The gastrin-releasing peptide receptor (GRPR) is overexpressed in various cancers, including prostate cancer, breast cancer, small cell and non–small cell lung cancer, uterine and ovarian cancer, ...

Worried about looming tariffs on tech? Our experts review more than 1,500 products each year. Our mega-guide, updated monthly, scopes out the very best cost-conscious picks across 15 key categories.